Atrás
Rango del Día
$20.74
$21.67
Rango de 52 Semanas
$10.57
$23.77
Volumen
1,552,403
Promedio 50D / 200D
$20.15
/
$16.67
Cierre Anterior
$20.17
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -6.5 | 0.4 |
| P/B | 3.3 | 2.9 |
| ROE % | -45.7 | 3.7 |
| Net Margin % | — | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Puntos Clave
Debt/Equity of 0.04 — conservative balance sheet
Negative free cash flow of -422.10M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-45.69%
ROIC-39.44%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.04
Current Ratio9.16
Interest Coverage0.00
Valoración
P/E Ratio
-6.53
P/B Ratio3.30
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -512.54M |
| ROE | -45.69% | ROA | -44.77% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -422.10M |
| ROIC | -39.44% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.04 | Current Ratio | 9.16 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -6.53 | P/B Ratio | 3.30 |
| P/S Ratio | N/A | PEG Ratio | -0.36 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 3.34B | Enterprise Value | 3.18B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 330.53M | 108.46M | 48.66M |
| Net Income | -512.54M | -422.77M | -145.22M | -325.99M | -290.58M |
| EPS (Diluted) | -2.97 | -2.57 | -1.06 | -2.60 | -2.39 |
| Gross Profit | -11.18M | 0.0 | 330.53M | 108.46M | 48.66M |
| Operating Income | -555.34M | -487.34M | -196.70M | -340.74M | -295.75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.14B | 1.37B | 1.15B | 1.46B | 1.40B |
| Total Liabilities | 131.09M | 144.50M | 122.96M | 417.81M | 441.87M |
| Shareholders' Equity | 1.01B | 1.23B | 1.03B | 1.04B | 962.29M |
| Total Debt | 42.29M | 48.71M | 52.24M | 60.35M | 64.01M |
| Cash & Equivalents | 205.33M | 174.96M | 127.11M | 218.04M | 293.48M |
| Current Assets | 900.66M | 864.44M | 1.06B | 1.37B | 897.23M |
| Current Liabilities | 98.35M | 102.21M | 77.98M | 363.92M | 378.25M |